Nat Genet (2006) 38:5838
Urva, et al., LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept, 2022, Cell Metabolism 34, 12341247
Heres why they work so well: Appetite Regulation: GLP-1 slows the rate at which the stomach empties, helping you feel full longer and reducing overall calorie intake
To the best of our knowledge, the effect of intravenously administered ghrelin on insulin secretion during an OGTT in mice has not been reported previously
Reconstitution: mixing your GLP-1 medication step by step Reconstitution is the process of adding bacteriostatic water to your lyophilized peptide powder to create an injectable solution
In some studies, lean mass loss represents as much as 25-40% of total weight lost